BrainsWay Ltd.

Healthcare · Medical Devices · Israel

Last price 11.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.39M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves ...